Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine
Frank W. Pun(Hong Kong Science and Technology Parks Corporation), Alex Zhavoronkov(Abu Dhabi University), Bonnie Hei Man Liu(Hong Kong Science and Technology Parks Corporation), Hoi-Wing Leung(Hong Kong Polytechnic University), Xi Long(Hong Kong Science and Technology Parks Corporation), Geoffrey Ho Duen Leung(Hong Kong Science and Technology Parks Corporation), João Pedro de Magalhães(University of Liverpool), Ivan V. Ozerov(Hong Kong Science and Technology Parks Corporation), Alexander Aliper(Insilico Medicine (United States)), Ju Wang(Jinan University), Evgeny Izumchenko(University of Chicago), Feng Ren(Henan Medical University), Alexey Moskalev(Skolkovo Institute of Science and Technology)
Cited by 82
Related Papers
Deep biomarkers of human aging: Application of deep neural networks to biomarker development
|Aging|2016|377
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
|Chemical Science|2023|322
Validation of biomarkers of aging
|Nature Medicine|2024|299
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
|Nature Biotechnology|2024|265
Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
|Journal of Chemical Information and Modeling|2023|196